Back to top
more

Myriad Genetics: (MYGN)

(Market Close from NSDQ)

 Add to portfolio

Save at Trade

$34.12 USD

34.12
438,263

+0.49 (1.44%)

Updated Jul 31, 2015 03:59 PM ET

Volume: 438,263

Open: $33.82

Prior Close: $33.64

Zacks Rank : 3-Hold [?]     3    

Style Scores [?] : Growth: F | Value: B | Momentum: D

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The three scores are based on the trading styles of Growth, Value, and Momentum.

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Balance Sheet

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

Fiscal Year End for MYRIAD GENETICS falls in the month of June.

All items in Millions except Per Share data.

6/30/2015 6/30/2014 6/30/2013 6/30/2012 6/30/2011
Assets          
Cash & Equivalents NA 186 372 341 346
Receivables NA 85 98 63 51
Notes Receivable NA 0 0 0 0
Inventories NA 24 5 12 6
Other Current Assets NA 27 9 7 15
Total Current Assets NA 322 484 422 418
Net Property & Equipment NA 35 28 24 23
Investments & Advances NA 84 159 114 71
Other Non-Current Assets NA 0 22 19 0
Deferred Charges NA 3 29 31 26
Intangibles NA 374 70 73 73
Deposits & Other Assets NA 5 13 8 0
Total Assets NA 824 804 691 611
Liabilities & Shareholders Equity 6/30/2015 6/30/2014 6/30/2013 6/30/2012 6/30/2011
Notes Payable NA 0 0 0 0
Accounts Payable NA 23 18 10 11
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 56 44 33 22
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 1 2 2 1
Total Current Liabilities NA 81 65 45 34
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 24 11 10 10
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 105 75 55 44
Shareholders Equity 6/30/2015 6/30/2014 6/30/2013 6/30/2012 6/30/2011
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 718 697 648 604
Retained Earnings NA 2 31 -13 -39
Other Equity NA -2 -0 -0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 719 729 636 567
Total Liabilities & Shareholder's Equity NA 824 804 691 611
Total Common Equity 0 719 729 636 567
Shares Outstanding 69.40 74.80 79.60 84.80 85.70
Book Value Per Share 0.00 9.61 9.15 7.50 6.61

Fiscal Year End for MYRIAD GENETICS falls in the month of June.

All items in Millions except Per Share data.

6/30/2015 3/31/2015 12/31/2014 9/30/2014 6/30/2014
Assets          
Cash & Equivalents NA 134 187 182 186
Receivables NA 95 87 87 85
Notes Receivable NA 0 0 0 0
Inventories NA 29 20 25 24
Other Current Assets NA 23 26 41 27
Total Current Assets NA 282 320 335 322
Net Property & Equipment NA 69 46 43 35
Investments & Advances NA 41 42 54 84
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 3
Intangibles NA 381 368 371 374
Deposits & Other Assets NA 5 5 5 5
Total Assets NA 779 782 809 824
Liabilities & Shareholders Equity 6/30/2015 3/31/2015 12/31/2014 9/30/2014 6/30/2014
Notes Payable NA 0 0 0 0
Accounts Payable NA 18 17 26 23
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 48 41 41 56
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 1 2 1 1
Total Current Liabilities NA 67 60 68 81
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 10 2 5 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 25 25 24
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 110 88 97 105
Shareholders Equity 6/30/2015 3/31/2015 12/31/2014 9/30/2014 6/30/2014
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 738 735 731 718
Retained Earnings NA -62 -37 -17 2
Other Equity NA -8 -4 -2 -2
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 669 694 712 719
Total Liabilities & Shareholder's Equity NA 779 782 809 824
Total Common Equity 0 669 694 712 719
Shares Outstanding 69.40 71.10 72.90 73.00 74.80
Book Value Per Share 0.00 9.41 9.52 9.76 9.61